Fluocinonide
Brand names: Fluocinonide
At a glance
- Medicare prescriptions, 2024
- 499,750
- Medicare drug cost
- $22.0M
- Average cost per prescription
- $43.98
- Clinicians who prescribed it
- 14,134
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Fluocinonide Topical Solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
From the FDA-approved prescribing information (label dated May 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Dermatology 45.4%
- Physician Assistants 16.9%
- Internal Medicine 11.9%
- Family Medicine 8.2%
- Nurse Practitioners 7.6%
- Podiatrists 3.7%
- Mohs Surgery 1.3%
- Dermatopathology 0.9%
- General Practice 0.6%
- ENT (Otolaryngology) 0.4%
- Geriatric Medicine 0.3%
- Rheumatology 0.3%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 9% from 2019 to 2024.
Biggest change by state since 2019
- Minnesota +18%
- Maryland +4%
- Illinois −1%
- New York −3%
- Colorado −5%
- Tennessee (smallest change) −33%
- Arkansas (smallest change) −28%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 1 maker on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Preferred Pharmaceuticals Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 0.5 mg | white cream | |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Mar 2026 · Sun Pharmaceutical Industries Inc · Class II
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.